Single-use technologies provide a barrier between operators and drug products, allowing for sterility and personnel safety in manufacturing.
Ben Wylie
Advertisement
Ben Wylie is head of Product Management and Marketing at ChargePoint Technologies.
Articles by Ben Wylie
Through the adoption of single-use technology, drug manufacturers have been able to adapt to the challenges posed by the COVID-19 pandemic.
Advertisement
Latest Updated Articles
The Evolving Aseptic Processing LandscapePublished: August 1st 2021 | Updated:
De-Risking Sterile Pharma Manufacture with SUTsPublished: November 16th 2023 | Updated:
Advertisement
Advertisement
